Scarica l'app Stockscreener
0.917
10.97%
-0.113
Precedente Chiudi:
$1.03
Aprire:
$1.02
Volume 24 ore:
45,797
Relative Volume:
0.61
Capitalizzazione di mercato:
$2.31M
Reddito:
$1.03M
Utile/perdita netta:
$-11.10M
Rapporto P/E:
-0.0139
EPS:
-66.0832
Flusso di cassa netto:
$-8.21M
1 W Prestazione:
-18.85%
1M Prestazione:
-33.07%
6M Prestazione:
-80.32%
1 anno Prestazione:
-97.16%
Intervallo 1D:
$0.9101
$1.02
Intervallo di 1 settimana:
$0.9101
$1.132
Portata 52W:
$0.9101
$36.32
Ispecimen Inc Stock (ISPC) Company Profile
Nome
Ispecimen Inc
Settore
Industria
Telefono
781-301-6700
Indirizzo
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, NTRA, A, IDXX
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
0.917 | 2.31M | 1.03M | -11.10M | -8.21M | -66.08 |
TMO
Thermo Fisher Scientific Inc
|
690.00 | 255.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
229.04 | 161.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
393.44 | 56.71B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.97 | 48.77B | 7.23B | 1.41B | 1.09B | 4.979 |
IDXX
Idexx Laboratories Inc
|
560.36 | 44.15B | 4.45B | 1.10B | 1.06B | 13.59 |
Ispecimen Inc Borsa (ISPC) Ultime notizie
iSpecimen Shareholders Approve Key Financing and Acquisition Actions - The Globe and Mail
More yes than no votes would approve iSpecimen (ISPC) reverse split on October 30. - Stock Titan
A hospital is checking a new lab analyzer before clinical testing begins. - Stock Titan
Up to 80% discounts on future financings at iSpecimen (NASDAQ: ISPC) hinge on a shareholder vote. - Stock Titan
iSpecimen Granted Nasdaq Extension to Regain Compliance - The Globe and Mail
iSpecimen Granted Nasdaq Extension to Regain Compliance - TipRanks
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - tradingview.com
ISPC Stock Holds Ground As iSpecimen Delivers Cancer Research Milestone - timothysykes.com
ISPC Stock Draws Attention After Major Cancer Research Win - StocksToTrade
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
ISPC Stock Draws Traders As Cancer Order Highlights Global Reach - timothysykes.com
ISPC Stock Draws Traders After Rapid Cancer Project Win - StocksToTrade
Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket - Benzinga
ISPECIMENDEAL VALUED AT $4.50 MLN: $2 MLN CASH, $2.50 MLN IN COMMON STOCKSEC FILING - Moomoo
iSpecimen to Acquire AI Assets from Foldlab AI for $4.5 Million - minichart.com.sg
iSpecimen to Acquire Foldlab AI Disease Analytics - TipRanks
iSpecimen (NASDAQ: ISPC) lines up reverse split and financings at up to an 80% discount - Stock Titan
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
iSpecimen Enters Asset Purchase Agreement With FoldLab AI On September 4 - TradingView
iSpecimen to Acquire Foldlab AI Assets for $4.5 Million, Stock in 5-Year Escrow - TradingView
ISpecimenEnters Asset Purchase Agreement W - Moomoo
Five-year lock-up anchors iSpecimen (NASDAQ: ISPC) AI asset deal - Stock Titan
iSpecimen announces special shareholder meeting - Bitget
ISpecimen Inc. entered into an asset purchase agreement to acquire certain artificial intelligence software, intellectual property and related assets of Foldlab AI Ltd from Foldlab AI Ltd. for $4.5 million. - marketscreener.com
iSpecimen (ISPC) Earnings Update: The EPS Result Is Below Expectation in the Latest Session; Trading Move - vinanet.vn
iSpecimen (ISPC) Earnings Update: The EPS Result Is Below Expectation in the Latest Session; Trading Move - siam.in
iSpecimen (ISPC) Earnings Snapshot: The Available Earnings Metric Delivers a Miss under the Current Snapshot; Post-Report: Shares Finish 4.62% Down in the Latest ReadingBalance Sheet Strength - vinanet.vn
iSpecimen (ISPC) Earnings Snapshot: The Available Earnings Metric Delivers a Miss under the Current Snapshot; Post-Report: Shares Finish 4.62% Down in the Latest ReadingBuyback Announcement Report - vinanet.vn
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com Nigeria
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com Canada
iSpecimen completes cancer research project in three weeks - Investing.com
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks - The Manila Times
iSpecimen completes cancer research project in three weeks By Investing.com - Investing.com UK
iSpecimen Delivers Hundreds of International Cancer Blood Specimens Within Three Weeks, Highlighting Biospecimen Network Capabilities - kalkine.ca
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - dars.gov.et
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - vinanet.vn
iSpecimen (ISPC) Quarter in Focus: EPS Does Not Reach the Reported Estimate for the Current Session - dars.gov.et
An online marketplace sent hundreds of cancer samples abroad in three weeks - Stock Titan
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordLong Term Entry Picks - vinanet.vn
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordContinuation Pattern Picks - siam.in
iSpecimen (ISPC) Close in Focus: Gains 8.84% to Reach $2.34; Price Context: the Supplied Trading Band Runs From $2.22 to $2.46 in the Available RecordElliott Wave Count - dars.gov.et
iSpecimen Inc. (ISPC) Pulls Back 2.81% to $2.25 as Traders Eye Key Support ZoneCall Dominated - vinanet.vn
iSpecimen Inc. (ISPC) Slips 2.81% as Shares Test Key Technical LevelsPrice Momentum Stocks - dars.gov.et
iSpecimen Inc. (ISPC) Pulls Back 2.81% to $2.25 as Traders Eye Key Support ZoneTrend Continuation Trade - dars.gov.et
iSpecimen Flags Going Concern Doubt After Q2 Revenue Falls 79% - Minichart
iSpecimen Pays $2 Million for Three-Month Marketing Agreement - minichart.com.sg
Ispecimen Stock Price Forecast. Should You Buy ISPC? - StockInvest.us
iSpecimen Engages IR Agency for Investor Marketing - TipRanks
iSpecimen (ISPC) revenue drops to $308K as losses deepen and cash burns - Stock Titan
iSpecimen | 10-Q: Q2 2026 Earnings Report - Moomoo
Ispecimen Inc Azioni (ISPC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):